ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 859 filers reported holding ISHARES TR in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $350,000 | +7.4% | 2,140 | -1.2% | 0.23% | 0.0% |
| Q1 2021 | $326,000 | -0.6% | 2,165 | 0.0% | 0.23% | -2.5% |
| Q4 2020 | $328,000 | +4.8% | 2,165 | -6.5% | 0.24% | -6.6% |
| Q3 2020 | $313,000 | +5.7% | 2,315 | +6.9% | 0.26% | -3.8% |
| Q2 2020 | $296,000 | +26.5% | 2,165 | -0.5% | 0.27% | +13.2% |
| Q1 2020 | $234,000 | -10.7% | 2,175 | 0.0% | 0.24% | +17.5% |
| Q4 2019 | $262,000 | +13.4% | 2,175 | -6.5% | 0.20% | +9.9% |
| Q3 2019 | $231,000 | -9.1% | 2,325 | 0.0% | 0.18% | -9.0% |
| Q2 2019 | $254,000 | -22.3% | 2,325 | -20.5% | 0.20% | -23.4% |
| Q1 2019 | $327,000 | +15.5% | 2,925 | -0.2% | 0.26% | +1.6% |
| Q4 2018 | $283,000 | -20.7% | 2,930 | 0.0% | 0.26% | -9.8% |
| Q3 2018 | $357,000 | +10.9% | 2,930 | 0.0% | 0.28% | +2.5% |
| Q2 2018 | $322,000 | -1.2% | 2,930 | -3.9% | 0.28% | -2.5% |
| Q1 2018 | $326,000 | -7.9% | 3,050 | -8.0% | 0.28% | -2.1% |
| Q4 2017 | $354,000 | – | 3,315 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |